Phase Genomics
2 known investors
Phase Genomics develops ultra-long-range genome sequencing technology and computational tools for analyzing genetic data in research, medicine, and agriculture. The platform enables scientists to identify chromosomal abnormalities, analyze complex microbial samples, construct reference genomes, and study genetic interactions.
AI & Machine LearningBiotechDeep Tech
Investors · 2
In the news
- Phase Genomics lands $1.5 million Gates Foundation grant - Puget Sound Business Journalbizjournals.com · 2024
- Phase Genomics Announces Funding to Accelerate Discovery of New Lysin-Based Precision Antimicrobials - Phase Genomicsphasegenomics.com · 2024
- Phase Genomics Raises $1.5M in Fundingfinsmes.com · 2024
- With New Funding, Phase Genomics Seeks to Eliminate One of Biology’s Biggest Blind Spots | AP Newsapnews.com · 2022
- Funding the Future of Cancer Research - Phase Genomicsphasegenomics.com · 2022
- With $1M in funding, Phase Genomics looks to crack genetic codes and discover unknown bacteria – GeekWiregeekwire.com · 2017